SCM Lifescience Co., Ltd. (298060) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for SCM Lifescience Co., Ltd. (298060:KRX), powered by AI.

Current Price
₩2,890
P/E Ratio
126.2
Market Cap
25.5B
Sector
Healthcare
What is the SCM Lifescience Co., Ltd. stock price forecast?

SCM Lifescience Co., Ltd. is currently trading at ₩2,890. View real-time AI analysis on Alpha Lenz.

What is SCM Lifescience Co., Ltd. insider trading activity?

View the latest insider trading data for SCM Lifescience Co., Ltd. on Alpha Lenz.

What is SCM Lifescience Co., Ltd.'s P/E ratio?

SCM Lifescience Co., Ltd.'s P/E ratio is 126.2.

SCM Lifescience Co., Ltd.

KRX · 298060
₩2,890+35(+1.23%)Market closedKRX regular session 09:00–15:30 KST
Ask about SCM Lifescience Co., Ltd.'s future dividend policy...
Alpha Chat Insight

SCM Lifescience Co., Ltd. trades at a P/E of 126.2 (premium valuation) with modest ROE of 0.8%. 3Y revenue CAGR of 291.9% highlights clear growth momentum.

Ask for details

Company Overview

SCM Lifescience Co., Ltd. is a biotechnology company primarily engaged in the research and development of advanced stem cell therapies. The company's specialized focus is on producing high-quality stem cells for therapeutic applications, aiming to address various complex medical conditions. SCM Lifescience operates within the healthcare sector, significantly impacting regenerative medicine and advancing scientific research. By leveraging innovative technologies and proprietary processes, the company is at the forefront of developing cutting-edge treatments that hold immense potential for improving patient outcomes and expanding the horizons of current medical possibilities. SCM Lifescience plays a critical role in pioneering procedures that may transform how diseases are treated in the future, thereby maintaining its importance in the biotech industry. The company's contributions are vital in strengthening the synergy between scientific advancements and practical healthcare solutions, furthering the goals of precision medicine.

CEO김유정
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩25,549,435,150Market Cap
₩23,839,029,790Revenue
8.84MShares Out
0Employees

Margins

18.49%Gross
-1.62%EBITDA
-19.00%Operating
-1.64%Pre-Tax
0.85%Net

Valuation

126.17P/E
0.71P/B
1.07EV/Sales
-62.41EV/EBITDA
-2.56P/FCF

Growth (CAGR)

291.93%Rev 3Yr
136.82%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

0.54%ROA
0.81%ROE
0.12%ROIC

Financial Health

₩6,961,409,680Cash & Cash Equivalents
₩8,962,023,490Net Debt
44.15%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

SCM Lifescience Co., Ltd. (ticker: 298060) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $25.5B.

The current price is ₩2,890 with a P/E ratio of 126.17x and P/B of 0.71x.

ROE is 0.81% and operating margin is -19.00%. Annual revenue is $23.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
SCM Lifescience Co., Ltd. (298060) Stock Forecast 2026 ₩2,890 — Price, Financials & Analyst Targets | Alpha Lenz